Michael E. Tepedino, M.D. — High Point, North Carolina

Michael E. Tepedino, M.D. is a clinical research site located in High Point, North Carolina, United States 27262.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Michael E. Tepedino, M.D. has participated in 2 clinical trials.

Therapeutic areas: Ocular Hypertension, Open Angle Glaucoma.

Sponsors: Aerie Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in High Point

Browse all research sites in North Carolina · View every site in High Point

• High Point Regional Hospital
• Wake Forest University
• Wake Forest University Health Sciences
• High Point University
• University of North Carolina Regional Physicians Hematology Oncology
• Highpoint Regional Hospital
• 8400366 - High Point Regional Hospital
• Peters Medical Research
• Dermatology Consulting Services
• High Point Clinical Trials Center
• Research Site
• Hayworth Cancer Center

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Michael E. Tepedino, M.D.?

Michael E. Tepedino, M.D. has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Michael E. Tepedino, M.D. conducted?

Michael E. Tepedino, M.D. has 2 clinical trials on record. Their work covers Ocular Hypertension, Open Angle Glaucoma.

Is Michael E. Tepedino, M.D. accredited by Crixeo Clinical Trials?

Michael E. Tepedino, M.D. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Michael E. Tepedino, M.D.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.